2008-07-24 08:00:00
Clarient to Release Second Quarter 2008 Financial Results on Wednesday, August 6
Conference Call and Audio Webcast Scheduled for 5 p.m. EDT
ALISO VIEJO, Calif.–(EMWNews)–Clarient, Inc. (Nasdaq:CLRT),
a premier anatomic pathology and molecular testing services resource for
pathologists, oncologists and the pharmaceutical industry, today
announced that it will report its financial results for the second
quarter and six months ended June 30, 2008 and certain future
expectations after the stock market closes on Wednesday, August 6.
|
Date: |
|
Wednesday, August 6, 2008 |
|
|
||
|
Start Time: |
5:00 p.m. EDT |
|
|
|
||
|
Call-in Number: |
1-866-844-2998 |
|
|
(International) 706-634-8595 |
||
|
|
||
|
Conference ID Number: |
57323903 |
|
|
|
||
|
Webcast: |
|
|
|
|
||
|
Web Replay: |
For those unable to participate during the live broadcast, the webcast replay will be archived at www.clarientinc.com/investor shortly after the call and will be available for one year. |
|
|
|
||
|
Host: |
Ronald A. Andrews, CEO and Vice Chairman |
|
|
|
||
|
Format: |
Discussion of second quarter 2008 financial results followed by Q&A |
About Clarient
Clarient combines innovative technologies with world class expertise to
assess and characterize cancer. Clarient’s
mission is to provide the services, resources and critical information
to improve the quality and reduce the cost of patient care as well as
accelerating the drug development process. The Company’s
principal customers include pathologists, oncologists, hospitals and
biopharmaceutical companies. The rise of individualized medicine as the
new direction in oncology has created the need for a centralized
resource providing leading diagnostic technologies such as flow
cytometry and molecular testing. Clarient is that resource, having
created a state-of-the-art commercial cancer laboratory providing the
most advanced oncology testing and drug development services available
both onsite and over the web. Clarient is a Safeguard Scientifics
partner company. www.clarientinc.com
About Safeguard Scientifics
Founded in 1953 and based in Wayne, PA, Safeguard Scientifics, Inc.
(NYSE:SFE) provides growth capital for entrepreneurial and innovative
technology and life sciences companies. Safeguard targets technology
companies in Software as a Service (SaaS) / Internet-based Businesses,
Technology-Enabled Services and Vertical Software Solutions, and life
sciences companies in Molecular and Point-of-Care Diagnostics, Medical
Devices and Specialty Pharmaceuticals with capital requirements between
$5 and $50 million. Safeguard participates in expansion financings,
corporate spin-outs, management buyouts, recapitalizations, industry
consolidations and early-stage financings. www.safeguard.com
|
Lippert/Heilshorn & Associates |
|
Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89
Get Unlimited Organic Website Traffic to your Website
TheNFG.com now offers Organic Lead Generation & Traffic Solutions
